Institutional investors purchased a net $114.5 thousand shares of DRRX during the quarter ended September 2017, and now own 44.90% of the total float, a percentage that is typical for companies in the Pharmaceuticals: Other industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
INGALLS & SNYDER LLC Bought 2.2 Million shares of DURECT Corp
RENAISSANCE TECHNOLOGIES LLC Bought 582.7 Thousand shares of DURECT Corp
BRIDGEWAY CAPITAL MANAGEMENT, IN... Bought 250.0 Thousand shares of DURECT Corp